Roche Pharma

Part of Roche

OrganisationROR

Trials

NCT06663098
Collaborator, Phase 2, Recruiting, 142 people, 29 Oct 2024
NCT05689671
Collaborator, Phase 4, Active, not recruiting, 136 people, 19 Jan 2023
NCT04888221
Collaborator, Phase 3, Active, not recruiting, 66 people, 17 May 2021
NCT04770272
Collaborator, Phase 2, Terminated, 442 people, 25 Feb 2021
NCT04702256
Collaborator, Phase 3, Recruiting, 196 people, 8 Jan 2021
NCT04661358
Collaborator, Phase 3, Active, not recruiting, 563 people, 10 Dec 2020
NCT04487756
Collaborator, Phase 1/2, Completed, 20 people, 27 Jul 2020
NCT04445272
Collaborator, Phase 2, Completed, 495 people, 24 Jun 2020
NCT04363853
Collaborator, Phase 2, Active, not recruiting, 200 people, 27 Apr 2020
NCT04335071
Collaborator, Phase 2, Terminated, 5 people, 6 Apr 2020
NCT04245085
Collaborator, Phase 2, Completed, 95 people, 28 Jan 2020
NCT04161248
Collaborator, Early phase 1, Active, not recruiting, 40 people, 13 Nov 2019
NCT03721653
Collaborator, Phase 2, Completed, 218 people, 26 Oct 2018
NCT03519295
Collaborator, Phase 2, Completed, 97 people, 8 May 2018
NCT03421288
Collaborator, Phase 2, Active, not recruiting, 677 people, 5 Feb 2018
NCT03341520
Collaborator, Phase 2, Completed, 89 people, 14 Nov 2017
NCT03340376
Collaborator, Phase 2, Status unknown, 48 people, 13 Nov 2017
NCT03272477
Collaborator, Phase 2, Completed, 257 people, 5 Sept 2017
NCT03192215
Collaborator, Phase 3, Terminated, 1,015 people, 20 Jun 2017
NCT03147040
Collaborator, Phase 2, Terminated, 23 people, 10 May 2017